Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoine Bouquegneau

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Current Opinion in Endocrinology, Diabetes, and Obesity|May 28, 2024
Insight into the potential of bone turnover biomarkers: integration in the management of osteoporosis and chronic kidney disease-associated osteoporosisPauline Brouwers, Antoine Bouquegneau, Etienne Cavalier
Revue Medicale Suisse|August 28, 2020
[How to estimate glomerular filtration rate in the context of drug dosage adaptation ?]Pierre Delanaye, Antoine Bouquegneau, Olivier Moranne, et al.
Kidney International|December 10, 2015
Sclerostin levels in CKD patients: an important, but not definitive, step on the way to clinical usePierre Delanaye, Etienne Cavalier, Antoine Bouquegneau, et al.
Revue Medicale De Liege|September 12, 2024
[English Title : Treatment of membranous nephropathy]Adrien Stoffels, François Jouret, Pauline Erpicum, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 3, 2014
Biomarkers and physiopathology in the cardiorenal syndromeAntoine Bouquegneau, Jean-Marie Krzesinski, Pierre Delanaye, et al.
Nephrologie & Therapeutique|September 26, 2022
[Diagnostic trap: Lithium neurotoxicity with normal lithemia]Hugo Tiv, Antoine Vandelaer, Pierre Delanaye, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 26, 2016
Bone Disease after Kidney TransplantationAntoine Bouquegneau, Syrazah Salam, Pierre Delanaye, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 22, 2012
Anorexia nervosa and the kidneyAntoine Bouquegneau, Bernard E Dubois, Jean-Marie Krzesinski, et al.
Nephrologie & Therapeutique|March 22, 2015
[The matrix-gla protein awakening may lead to the demise of vascular calcification]Pierre Delanaye, Sophie Liabeuf, Antoine Bouquegneau, et al.
Nephrologie & Therapeutique|December 2, 2017
[Lupus nephropathy: Insight in new treatments]Virginie Jadot, Jean-Marie Krzesinski, Christian Von Frenckell, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Current Opinion in Endocrinology, Diabetes, and Obesity|May 28, 2024
Insight into the potential of bone turnover biomarkers: integration in the management of osteoporosis and chronic kidney disease-associated osteoporosisPauline Brouwers, Antoine Bouquegneau, Etienne Cavalier
Revue Medicale Suisse|August 28, 2020
[How to estimate glomerular filtration rate in the context of drug dosage adaptation ?]Pierre Delanaye, Antoine Bouquegneau, Olivier Moranne, et al.
Kidney International|December 10, 2015
Sclerostin levels in CKD patients: an important, but not definitive, step on the way to clinical usePierre Delanaye, Etienne Cavalier, Antoine Bouquegneau, et al.
Revue Medicale De Liege|September 12, 2024
[English Title : Treatment of membranous nephropathy]Adrien Stoffels, François Jouret, Pauline Erpicum, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 3, 2014
Biomarkers and physiopathology in the cardiorenal syndromeAntoine Bouquegneau, Jean-Marie Krzesinski, Pierre Delanaye, et al.
Nephrologie & Therapeutique|September 26, 2022
[Diagnostic trap: Lithium neurotoxicity with normal lithemia]Hugo Tiv, Antoine Vandelaer, Pierre Delanaye, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 26, 2016
Bone Disease after Kidney TransplantationAntoine Bouquegneau, Syrazah Salam, Pierre Delanaye, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 22, 2012
Anorexia nervosa and the kidneyAntoine Bouquegneau, Bernard E Dubois, Jean-Marie Krzesinski, et al.
Nephrologie & Therapeutique|March 22, 2015
[The matrix-gla protein awakening may lead to the demise of vascular calcification]Pierre Delanaye, Sophie Liabeuf, Antoine Bouquegneau, et al.
Nephrologie & Therapeutique|December 2, 2017
[Lupus nephropathy: Insight in new treatments]Virginie Jadot, Jean-Marie Krzesinski, Christian Von Frenckell, et al.
Pageof 5